Circulating Exosomes Inhibit B Cell Proliferation and Activity.

B cells Bruton’s tyrosine kinase Head and Neck Cancer exosomes

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
29 Jul 2020
Historique:
received: 23 06 2020
revised: 19 07 2020
accepted: 24 07 2020
entrez: 6 8 2020
pubmed: 6 8 2020
medline: 6 8 2020
Statut: epublish

Résumé

(1) Background: Head and neck squamous cell carcinoma (HNSCC) is characterized by a distinctive suppression of the anti-tumor immunity, both locally in the tumor microenvironment (TME) and the periphery. Tumor-derived exosomes mediate this immune suppression by directly suppressing T effector function and by inducing differentiation of regulatory T cells. However, little is known about the effects of exosomes on B cells. (2) Methods: Peripheral B cells from healthy donors and HNSCC patients were isolated and checkpoint receptor expression was analyzed by flow cytometry. Circulating exosomes were isolated from the plasma of HNSCC patients (

Identifiants

pubmed: 32751214
pii: cancers12082110
doi: 10.3390/cancers12082110
pmc: PMC7464446
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Deutsche Forschungsgemeinschaft
ID : SCHU 2536/3
Organisme : Deutsche Forschungsgemeinschaft
ID : TH 2172/2-1

Références

Mol Immunol. 2004 Jul;41(6-7):599-613
pubmed: 15219998
Semin Cancer Biol. 2015 Dec;35 Suppl:S185-S198
pubmed: 25818339
Clin Cancer Res. 2002 Aug;8(8):2553-62
pubmed: 12171883
Front Oncol. 2018 Oct 12;8:445
pubmed: 30370252
QJM. 2019 Jun 26;:
pubmed: 31250021
J Cell Biol. 2013 Feb 18;200(4):373-83
pubmed: 23420871
J Immunother Cancer. 2019 Nov 21;7(1):313
pubmed: 31753019
Cancer Res. 2017 Dec 1;77(23):6480-6488
pubmed: 29162616
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Blood. 2013 Jul 4;122(1):9-18
pubmed: 23678003
Eur J Immunol. 2005 Jul;35(7):2081-8
pubmed: 15971272
Oncoimmunology. 2020 Apr 7;9(1):1747732
pubmed: 32313730
J Immunol. 2009 Feb 1;182(3):1509-17
pubmed: 19155498
Cancer Immunol Immunother. 2020 Jul;69(7):1205-1216
pubmed: 32146518
Cells. 2019 Feb 12;8(2):
pubmed: 30759880
Cell Mol Immunol. 2017 Aug;14(8):662-674
pubmed: 28626234
J Clin Oncol. 2015 Oct 10;33(29):3293-304
pubmed: 26351330
Mol Immunol. 2019 May;109:20-26
pubmed: 30851633
Immunology. 2005 Dec;116(4):464-76
pubmed: 16313360
Methods. 2015 Oct 1;87:3-10
pubmed: 25766927
Int Immunol. 2013 Feb;25(2):129-37
pubmed: 23087177
Clin Cancer Res. 2018 Feb 15;24(4):896-905
pubmed: 29233903
PLoS One. 2012;7(2):e31632
pubmed: 22328941
Clin Exp Immunol. 2017 Sep;189(3):259-267
pubmed: 28369805
Cell Mol Life Sci. 2015 Feb;72(4):659-71
pubmed: 25336151
J Clin Invest. 2016 Apr 1;126(4):1173-80
pubmed: 27035808
J Immunother Cancer. 2018 Dec 10;6(1):145
pubmed: 30526680
J Extracell Vesicles. 2016 Mar 24;5:29289
pubmed: 27018366
J Immunol. 2010 Jan 15;184(2):787-95
pubmed: 20008291
Exp Hematol Oncol. 2012 Nov 29;1(1):36
pubmed: 23210908
Expert Opin Biol Ther. 2014 Oct;14(10):1411-25
pubmed: 24934899
Cancer Discov. 2016 May;6(5):546-59
pubmed: 26928313
Clin Cancer Res. 2002 Oct;8(10):3137-45
pubmed: 12374681
Cancer Res. 2017 Sep 15;77(18):5118-5128
pubmed: 28716895
Nat Rev Cancer. 2013 Dec;13(12):842-57
pubmed: 24226193
J Immunol. 2004 May 15;172(10):5931-9
pubmed: 15128774
Clin Exp Immunol. 2018 Jun;192(3):271-283
pubmed: 29431869
Cancer Sci. 2019 Sep;110(9):2700-2710
pubmed: 31276257
Nat Immunol. 2002 Feb;3(2):135-42
pubmed: 11812990
J Immunol. 2019 May 1;202(9):2806-2816
pubmed: 30910862
PLoS One. 2013 May 16;8(5):e64425
pubmed: 23696891
J Clin Invest. 2016 Apr 1;126(4):1216-23
pubmed: 26927673
Oncoimmunology. 2019 Apr 24;8(7):1593805
pubmed: 31143513
Sci Rep. 2016 Feb 04;6:20254
pubmed: 26842680
Clin Cancer Res. 2018 Jan 1;24(1):6-13
pubmed: 28751445
Clin Cancer Res. 2017 Aug 15;23(16):4843-4854
pubmed: 28400428
Clin Exp Immunol. 2018 Oct;194(1):67-78
pubmed: 30229863
J Immunol. 2007 Dec 1;179(11):7316-24
pubmed: 18025174
Cell Mol Neurobiol. 2016 Apr;36(3):301-12
pubmed: 27053351
Science. 2018 Mar 23;359(6382):1350-1355
pubmed: 29567705
J Immunol. 1995 Aug 15;155(4):1776-83
pubmed: 7543532
Cell. 2010 Mar 19;140(6):883-99
pubmed: 20303878

Auteurs

Jan C Schroeder (JC)

Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University, 89075 Ulm, Germany.

Lisa Puntigam (L)

Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University, 89075 Ulm, Germany.

Linda Hofmann (L)

Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University, 89075 Ulm, Germany.

Sandra S Jeske (SS)

Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University, 89075 Ulm, Germany.

Inga J Beccard (IJ)

Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University, 89075 Ulm, Germany.

Johannes Doescher (J)

Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University, 89075 Ulm, Germany.

Simon Laban (S)

Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University, 89075 Ulm, Germany.

Thomas K Hoffmann (TK)

Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University, 89075 Ulm, Germany.

Cornelia Brunner (C)

Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University, 89075 Ulm, Germany.

Marie-Nicole Theodoraki (MN)

Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University, 89075 Ulm, Germany.

Patrick J Schuler (PJ)

Department of Otorhinolaryngology and Head and Neck Surgery, Ulm University, 89075 Ulm, Germany.

Classifications MeSH